Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Hyeonju Oh, Seon-Kyeong Jang, Hyeon-Seung Lee, Eun-Byeol Lee & Kee-Hong Choi. (2021) Personality Traits in Individuals with the Dual Diagnosis of Psychosis and Substance Use Disorders: A Comprehensive Review and Meta-Analysis. Journal of Dual Diagnosis 17:1, pages 34-51.
Read now
Read now
E. Sherwood Brown. (2017) Epilogue to Dual Diagnosis Special Issue. The American Journal of Drug and Alcohol Abuse 43:4, pages 489-490.
Read now
Read now
Articles from other publishers (17)
Sabrina Snyder, Niyati Butala, Andrew M. Williams & Jamie Kneebusch. (2024) Pharmacist-Driven Alcohol Use Disorder Screening May Increase Inpatient Utilization of Extended-Release Naltrexone: A Single Center Pilot Study. Pharmacy 12:1, pages 26.
Crossref
Crossref
Antonio Vita, Stefano Barlati, Giacomo Deste, Gabriele Nibbio, David L. Penn, Amy E. Pinkham, Roger S. McIntyre & Philip D. Harvey. (2023) Life engagement in people living with schizophrenia: predictors and correlates of patient life engagement in a large sample of people living in the community. Psychological Medicine 53:16, pages 7943-7952.
Crossref
Crossref
Fabien Gierski, Farid Benzerouk, Jérôme Jeanblanc, Bernard Angerville, Alain Dervaux, Arthur Kaladjian & Mickaël Naassila. (2022) Validity and usefulness of the short form of the Drinking Motives Questionnaire Revised (DMQ-R SF) among patients with schizophrenia. Addictive Behaviors 129, pages 107251.
Crossref
Crossref
Samantha Johnstone, Maryam Sorkhou, Nada Al-Saghir, Darby J. E. Lowe, Vaughn R. Steele, Godfrey D. Pearlson, David J. Castle & Tony P. George. (2022) Neuromodulation to Treat Substance Use Disorders in People With Schizophrenia and Other Psychoses: A Systematic Review. Frontiers in Psychiatry 13.
Crossref
Crossref
Falk Kiefer, Sabine Hoffmann, Julia Arens, Martin Beutel, Oliver Bilke-Hentsch, Gallus Bischof, Udo Bonnet, Jan Malte Bumb, Ralf Demmel, Silke Diestelkamp, Patric Driessen, Isabel Englert, Ursula Fennen, Heribert Fleischmann, Jennis Freyer-Adam, Wilma Funke, Dieter Geyer, Euphrosyne Gouzoulis-Mayfrank, Renate Hannak-Zeltner, Barbara Hansen, Ursula Havemann-Reinecke, Derik Hermann, Eva Hoch, Werner Höhl, Susann Hößelbarth, Kristin Hupfer, Julia Jückstock, Marianne Klein, Andreas Koch, Joachim Köhler, Michael Köhnke, Anne Koopmann, Oliver Kreh, Monika Krönes, Dietmar Kramer, Georg Kremer, Timo Krüger, Nikolaus Lange, Bodo Lieb, Johannes Lindenmeyer, Mathias Luderer, Karl Mann, Peter Missel, Sebastian Mueller, Michael Müller-Mohnssen, Corinna Nels-Lindemann, Tim Neumann, Thomas Polak, Ulrich W. Preuss, Olaf Reis, Gerhard Reymann, Monika Ridinger, Hans-Jürgen Rumpf, Peter-Michael Sack, Ingo Schäfer, Martin Schäfer, Norbert Scherbaum, Ariane Schulte, Welf Schroeder, Manfred Singer, Michael Soyka, Rainer Thomasius, Clemens Veltrup, Monika Vogelgesang, Irmgard Vogt, Marc Walter, Tillmann Weber, Georg Weil, Bernd Wessel, Tina Wessels, Klaudia Winkler, Nadja Wirth, Arnold Wieczorek, Norbert Wodarz & Dirk Wolter. 2022. S3-Leitlinie Screening, Diagnose und Behandlung alkoholbezogener Störungen. S3-Leitlinie Screening, Diagnose und Behandlung alkoholbezogener Störungen
51
356
.
Alexandria S. Coles, Dunja Knezevic, Tony P. George, Christoph U. Correll, John M. Kane & David Castle. (2021) Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review. Frontiers in Psychiatry 12.
Crossref
Crossref
Arthur S. Nguyen, Rebecca Grossman-Kahn & Lora Wichser. (2020) Anticipatory Clozapine Dosing After Discharge From Inpatient Treatment for the Patient With Comorbid Schizophrenia and Tobacco Use. Journal of Clinical Psychopharmacology 40:6, pages 618-619.
Crossref
Crossref
Anna Meneghelli, Simona Barbera, Maria Meliante, Emiliano Monzani, Antonio Preti, Angelo Cocchi & Mauro Percudani. (2020) Outcome at 2-year of treatment in first-episode psychosis patients who were enrolled in a specialized early intervention program. Psychiatry Research 291, pages 113200.
Crossref
Crossref
Simone N. Vigod, Kinwah Fung, Abigail Amartey, Emily Bartsch, Reema Felemban, Natasha Saunders, Astrid Guttmann, Maria Chiu, Lucy C. Barker, Paul Kurdyak & Hilary K. Brown. (2019) Maternal schizophrenia and adverse birth outcomes: what mediates the risk?. Social Psychiatry and Psychiatric Epidemiology 55:5, pages 561-570.
Crossref
Crossref
Glenn E Hunt, Nandi Siegfried, Kirsten Morley, Carrie Brooke-Sumner & Michelle Cleary. (2019) Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews 2019:12.
Crossref
Crossref
Joseph Firth, Najma Siddiqi, Ai Koyanagi, Dan Siskind, Simon Rosenbaum, Cherrie Galletly, Stephanie Allan, Constanza Caneo, Rebekah Carney, Andre F Carvalho, Mary Lou Chatterton, Christoph U Correll, Jackie Curtis, Fiona Gaughran, Adrian Heald, Erin Hoare, Sarah E Jackson, Steve Kisely, Karina Lovell, Mario Maj, Patrick D McGorry, Cathrine Mihalopoulos, Hannah Myles, Brian O'Donoghue, Toby Pillinger, Jerome Sarris, Felipe B Schuch, David Shiers, Lee Smith, Marco Solmi, Shuichi Suetani, Johanna Taylor, Scott B Teasdale, Graham Thornicroft, John Torous, Tim Usherwood, Davy Vancampfort, Nicola Veronese, Philip B Ward, Alison R Yung, Eoin Killackey & Brendon Stubbs. (2019) The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. The Lancet Psychiatry 6:8, pages 675-712.
Crossref
Crossref
Pratima Murthy, Jayant Mahadevan & Prabhat K. Chand. (2019) Treatment of substance use disorders with co-occurring severe mental health disorders. Current Opinion in Psychiatry 32:4, pages 293-299.
Crossref
Crossref
Je-Yeon YunJung Suk LeeShi Hyun KangBeomwoo NamSeung Jae LeeSeung-Hwan LeeJoonho ChoiChan-Hyung KimYoung-Chul Chung. (2019) Korean Treatment Guideline on Pharmacotherapy of Co-existing Symptoms and Antipsychotics-related Side Effects in Patients with Schizophrenia. Korean Journal of Schizophrenia Research 22:2, pages 21.
Crossref
Crossref
Itai Danovitch & David A. Gorelick. 2019. The Assessment and Treatment of Addiction. The Assessment and Treatment of Addiction
105
121
.
David A. Gorelick. 2019. Cannabis Use Disorders. Cannabis Use Disorders
113
125
.
Glenn E. Hunt, Matthew M. Large, Michelle Cleary, Harry Man Xiong Lai & John B. Saunders. (2018) Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990–2017: Systematic review and meta-analysis. Drug and Alcohol Dependence 191, pages 234-258.
Crossref
Crossref
Alain Dervaux & Xavier Laqueille. (2018) Comorbidités psychiatriques de l’alcoolodépendance. La Presse Médicale 47:6, pages 575-585.
Crossref
Crossref